Table 2.
Expression levels of AGTR1 in 31 cancer types and matched non-tumor samples and the relationship between high AGTR1 expression in tumor tissues and patient survival
| Tumor | T Median | N Median | HR (high) | P (HR) | logrankP |
|---|---|---|---|---|---|
| ACC | 10.04 | 29.98 | 1.2 | 0.63 | 0.62 |
| BLCA | 0.21 | 8.32 | 1.5 | 0.0065 | 0.006 |
| BRCA | 1.89 | 21.87 | 1.1 | 0.47 | 0.47 |
| CESC | 0.05 | 3.01 | 0.97 | 0.89 | 0.89 |
| CHOL | 2.83 | 29.62 | 2.1 | 0.14 | 0.13 |
| COAD | 0.09 | 11.07 | 1.6 | 0.053 | 0.05 |
| DLBC | 0.05 | 0.02 | 1.8 | 0.42 | 0.41 |
| ESCA | 0.17 | 1.01 | 0.75 | 0.22 | 0.22 |
| GBM | 0.35 | 0.11 | 1.5 | 0.043 | 0.042 |
| HNSC | 0.08 | 0.21 | 1.2 | 0.24 | 0.24 |
| KICH | 0.7 | 6.33 | 0.76 | 0.66 | 0.66 |
| KIRC | 4.94 | 6.92 | 0.58 | 0.00047 | 4.00E-04 |
| KIRP | 0.29 | 5.4 | 0.68 | 0.21 | 0.21 |
| LAML | 0.1 | 0.02 | 1.2 | 0.44 | 0.44 |
| LGG | 0.09 | 0.11 | 1.5 | 0.041 | 0.039 |
| LIHC | 14.21 | 26.29 | 0.96 | 0.83 | 0.83 |
| LUAD | 0.61 | 10.09 | 0.84 | 0.26 | 0.26 |
| LUSC | 0.28 | 10.2 | 1.3 | 0.09 | 0.09 |
| OV | 0.16 | 2.06 | 0.96 | 0.77 | 0.78 |
| PAAD | 1.17 | 1.36 | 0.6 | 0.018 | 0.016 |
| PCPG | 2.14 | 34.36 | 0.25 | 0.22 | 0.19 |
| PRAD | 5.54 | 4.19 | 1.8 | 0.37 | 0.37 |
| READ | 0.26 | 12.72 | 2.7 | 0.061 | 0.051 |
| SARC | 1.92 | 7.69 | 0.76 | 0.17 | 0.17 |
| SKCM | 0.11 | 9.43 | 1.3 | 0.041 | 0.039 |
| STAD | 0.27 | 1.38 | 1.4 | 0.063 | 0.062 |
| TGCT | 0.39 | 2.3 | 3.1 | 0.33 | 0.31 |
| THCA | 0.45 | 12.09 | 0.91 | 0.85 | 0.85 |
| THYM | 0.14 | 0.02 | 0.13 | 0.063 | 0.03 |
| UCEC | 0.05 | 4.11 | 2.3 | 0.023 | 0.02 |
| UCS | 0.83 | 4.22 | 1.2 | 0.65 | 0.67 |
Blue indicates that the expression of AGTR1 in tumor groups and normal tissues is significantly different. The data were obtained through Gene Expression Profiling Interactive Analysis (GEPIA). T median: Median expression of tumor tissue; N median: median expression of normal tissue.